STM publisher Elsevier, Netherlands, has announced the highlights of its journal Impact Factor performance in 2010. According to the 2010 Journal Citation Reports published by Thomson Reuters, Elsevier saw over 55 percent of its journal Impact Factors increase from 2009 to 2010. Non-Elsevier journals showed an increased Impact Factor of slightly over 49 percent. In addition, 23 percent of Elsevier journals were ranked in the top 10 percent of their category.
The Lancet and all three Lancet specialty journals improved their Impact Factors this year. The Lancet went up from 30.758 to 33.633, ranking 2nd in the Medicine, General and Internal category. Lancet Infectious Diseases and Lancet Neurology retained their #1 rankings in their respective categories, while Lancet Oncology saw its Impact Factor increase from 14.470 to 17.764.
Cell, the flagship journal of Cell Press, saw its Impact Factor increase from 31.152 to 32.401 and remains the number one research journal in the Cell Biology and Biochemistry & Molecular Biology subject categories. The impact factor for Immunity showed an impressive 18 percent increase to 24.221. Among Cell Press's more recent suite of journal launches, Cancer Cell delivered a strong performance by showing an increase of almost 7 percent to 26.925, while Cell Stem Cell (increase to 25.943) and Cell Host & Microbe (increase to 13.728) continue to grow in their third year of impact factors.
In addition, 67 Elsevier journals earned their first Impact Factor this year. Some of these journals received very impressive scores.
Search for more Journal Impact Factors
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
